These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6860532)

  • 1. Use of a bioassay in healthy men to evaluate diuretic-spironolactone combinations.
    McInnes GT; Shelton JR; Perkins RM; Harrison IR; Clarke JM
    Br J Clin Pharmacol; 1983 May; 15(5):564-6. PubMed ID: 6860532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response relationships for spironolactone in combination with a potassium-wasting diuretic.
    McInnes GT; Clarke JM; Shelton JR
    Clin Pharmacol Ther; 1983 Jan; 33(1):35-43. PubMed ID: 6848297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative potency of prorenoate potassium and spironolactone in attenuating diuretic induced hypokalaemia.
    McInnes GT; Harrison IR; Shelton JR; Perkins RM; Clarke JM
    Br J Clin Pharmacol; 1984 Aug; 18(2):169-74. PubMed ID: 6487456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metolazone and spironolactone in cirrhosis and the nephrotic syndrome.
    Lang GR; Westenfelder C; Nascimento L; Dhupelia VB; Arruda JA; Kane RE
    Clin Pharmacol Ther; 1977 Feb; 21(2):234-43. PubMed ID: 319937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diuretic induced hypokalaemia: relationship to dosage interval and plasma aldosterone.
    McInnes GT; Shelton JR; Harrison IR; Perkins RM; Rigby GV
    Br J Clin Pharmacol; 1982 Sep; 14(3):449-52. PubMed ID: 7126418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effect of bumetanide and metolazone in normal volunteers.
    Greenberg A; Wallia R; Puschett JB
    J Clin Pharmacol; 1985; 25(5):369-73. PubMed ID: 4031114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the potassium and magnesium-sparing properties of amiloride and spironolactone in diuretic-treated normal subjects.
    Murdoch DL; Forrest G; Davies DL; McInnes GT
    Br J Clin Pharmacol; 1993 Apr; 35(4):373-8. PubMed ID: 8485017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diuretic action of metolazone in dogs.
    Yukimura T; Imanishi M; Abe Y; Yamamoto K
    Jpn J Pharmacol; 1979 Feb; 29(1):113-23. PubMed ID: 459149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Some effects of metolazone on electrolyte transport.
    Odlind B; Beermann B; Lindström B; Eriksson O
    Ups J Med Sci; 1987; 92(1):19-35. PubMed ID: 3590397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations.
    Snitker S; Doerfler RM; Soliman EZ; Deo R; St Peter WL; Kramlik S; Fischer MJ; Navaneethan S; Delafontaine P; Jaar BG; Ojo A; Makos GK; Slaven A; Weir MR; Zhan M; Fink JC;
    Clin J Am Soc Nephrol; 2017 Sep; 12(9):1409-1417. PubMed ID: 28793999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of the diuretic action of parenteral formulations of metolazone.
    Cvetanovic I; Ranade V; Molnar J; Whelton A; Somberg J
    Am J Ther; 2007; 14(1):25-9. PubMed ID: 17303972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic interaction between furosemide and metolazone in man.
    Marone C; Muggli F; Lahn W; Frey FJ
    Eur J Clin Invest; 1985 Oct; 15(5):253-7. PubMed ID: 3935455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature.
    Rosenberg J; Gustafsson F; Galatius S; Hildebrandt PR
    Cardiovasc Drugs Ther; 2005 Aug; 19(4):301-6. PubMed ID: 16189620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pharmacological study on diuretic action of 2-methyl-3-(o-tolyl)-6-sulfamyl-7-chloro-1, 2, 3, 4-tetrahydro-4-quinazolinone (metolazone) (author's transl)].
    Morimoto S; Fukuhara A; Matsumura Y
    Nihon Yakurigaku Zasshi; 1978 Mar; 74(2):239-49. PubMed ID: 658839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diuretic effect of furosemide metolazone combination in anaesthetized dogs.
    Raghu CN; Kshirsagar NA; Sheth UK
    Indian J Exp Biol; 1978 Jul; 16(7):832-4. PubMed ID: 700831
    [No Abstract]   [Full Text] [Related]  

  • 16. Spironolactone dose-response relationships in healthy subjects.
    McInnes GT; Perkins RM; Shelton JR; Harrison IR
    Br J Clin Pharmacol; 1982 Apr; 13(4):513-8. PubMed ID: 7066166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of chlorothiazide and of metolazone in the treatment of hypertension.
    Hua AS; Kincaid-Smith P
    Clin Sci Mol Med Suppl; 1976 Dec; 3():627s-629s. PubMed ID: 1071694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-response relationships for spironolactone at steady state.
    McInnes GT; Perkins RM; Shelton JR; Harrison IR
    Clin Pharmacol Ther; 1982 Mar; 31(3):317-23. PubMed ID: 7060315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diuretics and bone loss in rats with aldosteronism.
    Law PH; Sun Y; Bhattacharya SK; Chhokar VS; Weber KT
    J Am Coll Cardiol; 2005 Jul; 46(1):142-6. PubMed ID: 15992648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of nonsteroidal agents (NSAIDs) on the pharmacokinetics and pharmacodynamics of metolazone.
    Ripley EB; Gehr TW; Wallace H; Wade J; Kish C; Sica DA
    Int J Clin Pharmacol Ther; 1994 Jan; 32(1):12-8. PubMed ID: 8199745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.